Lon Cardon

Lon Ray Cardon FMedSci is an American statistical geneticist who is Chief Scientific Officer at BioMarin Pharmaceutical. Before joining BioMarin in 2017, he had conducted research on the genetic basis of human diseases for over twenty-five years. He had previously served as a full professor at the University of Oxford in the United Kingdom, and at the University of Washington and Fred Hutchinson Cancer Research Center in the United States. He subsequently entered the pharmaceutical industry as a senior vice president at GlaxoSmithKline. In this industry, he has attempted to translate the results of genetic research regarding the causes of human diseases into improved medical treatments.[2][3] He was elected to the Academy of Medical Sciences in 2005. He is also a fellow of the American Association for the Advancement of Science[2] and a former Wellcome Trust Principal Research Fellow.[3]

Lon R. Cardon

FMedSci
Born
Lon Ray Cardon
NationalityUnited States
EducationUniversity of Puget Sound
University of Colorado at Boulder[1]
AwardsWellcome Trust Principal Research Fellow
Scientific career
FieldsMedical genetics
Statistical genetics
InstitutionsBioMarin Pharmaceutical
Fred Hutchinson Cancer Research Center
GlaxoSmithKline
University of Oxford
University of Washington
ThesisMultivariate path analysis of specific cognitive abilities in the Colorado Adoption Project (1992)
Doctoral advisorDavid W. Fulker
Doctoral studentsGonçalo Abecasis

References
  1. "Frontiers in Population Genomics Research Meeting: Participants". National Human Genome Research Institute (NHGRI). Retrieved 2 March 2019.
  2. "Lon Cardon". All of Us Research Program. Retrieved 2 March 2019.
  3. "Professor Lon Cardon". The Academy of Medical Sciences. Retrieved 2 March 2019.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.